Author

Naveen K H Nagaiah

Observed names: Naveen K. H. Nagaiah, Naveen K.H. Nagaiah, Naveen KH Nagaiah, Naveen Nagaiah

Institutions: Mayo Clinic in Florida, Mayo Clinic Comprehensive Cancer Center (Florida)

Observed institutions: Mayo Clinic, Mayo Clinic in Florida, Mayo Clinic Comprehensive Cancer Center (Florida)

OpenAlex ID: A5046960266

The hidden architects of glioblastoma multiforme: Glioma stem cells

2024 · Om S. Sahoo, Rhiti Mitra, et al. · MedComm – Oncology · 32

MT-125 inhibits non-muscle myosin IIA and IIB and prolongs survival in glioblastoma

2025 · Rajappa S. Kenchappa, Laszlo Radnai, et al. · Cell · 21

Resistance to spindle inhibitors in glioblastoma depends on STAT3 and therapy induced senescence

2024 · Natanael Zarco, Athanassios Dovas, et al. · iScience · 2

MT-125 Inhibits Non-Muscle Myosin IIA and IIB, Synergizes with Oncogenic Kinase Inhibitors, and Prolongs Survival in Glioblastoma

2024 · Rajappa Kenchappa, Laszlo Radnai, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2

Abstract 16757: Immunomodulatory Hydrogel Promotes Survival of Mesenchymal Stem Cells in a Rat Model of Myocardial Infarction

2020 · Michaela Olthoff, Naveen Nagaiah, et al. · Circulation · 2

Microtubule Acetylation Regulates the Malignant Phenotype of Glioblastoma and is a Promising Therapeutic Target

2026 · Natanael Zarco, Athanassios Dovas, et al. · bioRxiv (Cold Spring Harbor Laboratory)

Works count: 6

Citation count: 59

H-index: 2

I10-index: 2